机译:Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Department of Molecular Carcinogenesis Netherlands Cancer Institute;
The Vancouver Prostate Centre and Department of Urologic Sciences University of British Columbia;
Core Facility Molecular Pathology & Biobanking Netherlands Cancer InstituteCore Facility Genomics Netherlands Cancer InstituteDepartment of Urology Erasmus MC Cancer Institute University Medical CenterLaboratory and Department of Urology Hospital Clínic de Barcelona Institut d'Investigacions BiomDepartment of BioMedical Research University of BernDepartment of Urology University of Washington School of MedicineDepartment of Surgical Oncology (Urology) Netherlands Cancer Institute;
Cisplatin-based chemotherapy; DNA sequencing; Muscle-invasive bladder cancer; Neoadjuvant chemotherapy; Response prediction; Somatic mutations;